Back to search

Chronic systemic high‐dose recombinant interferon alfa‐2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing‐remitting multiple sclerosis

Luca Durelli, Maria Roberta Bongioanni, Rossana Cavallo, Bruno Ferrero, Renata Ferri
DOI: 10.1212/wnl.44.3_part_1.406
Neurology

Data up to Jan 2025

Published1994
Citations119
References0
Fields
MedicineInternal medicineGastroenterologySurgery

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Chronic systemic high‐dose recombinant interferon alfa‐2a reduces exacerbation rate, MRI… (1994) – Neurology | Metascience Observatory Explorer